AD17002
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for AD17002, covering 2023-12-22 to 2025-11-26. Get the full timeline:
Most recent: Clinical Trial Update: A Multi-dose Study on the Safety and Efficacy of Self-administered Intranasal AD17002 Treatment for Eosinophilic Asthma [Phase 2]